Centre for Anaesthesiological Research, Department of Anesthesiology and Intensive Care Medicine, Zealand University Hospital, Denmark.
Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.
Acta Anaesthesiol Scand. 2025 Jan;69(1):e14526. doi: 10.1111/aas.14526. Epub 2024 Oct 18.
The anterior quadratus lumborum (QL) block may be used for postoperative pain management for intra-abdominal surgeries, but the evidence is uncertain. We aimed to investigate the benefit and harm of the anterior QL block compared to placebo/no block for intra-abdominal surgery.
We searched Medline, Embase, and CENTRAL for randomized controlled trials investigating anterior QL block for postoperative pain management for adult patients undergoing any intra-abdominal surgery. The two co-primary outcomes were cumulative 24-h opioid consumption and serious adverse events. We performed meta-analysis, trial sequential analysis (TSA), assessed the risk of bias, and present the certainty of evidence with the Grading of Recommendations, Assessment, Development and Evaluation approach.
Thirty-five trials randomizing 2418 patients were included in the meta-analyses. Anterior QL block may reduce cumulative 24-h intravenous opioid consumption compared to placebo/no block (MD -10.42 mg, 96.7% CI -14.83 to -6.01, TSA-adjusted CI -17.03 to -3.82, p < .01). Two trials reported on SAEs. Anterior QL block may have little to no effect on the number of serious adverse events compared to placebo (RR 1.49, 96.7% CI 0.19 to 11.47, p = .68), but the evidence is very uncertain. All trial results were assessed as being high risk of bias.
The anterior QL block may reduce cumulative 24-h opioid consumption. Reported serious adverse events were few and the anterior QL block may have little to no effect on the number of SAEs, but the evidence was very uncertain.
腹横肌前锯肌(QL)阻滞可用于腹部手术后的疼痛管理,但证据不确定。我们旨在研究腹横肌前锯肌阻滞与安慰剂/无阻滞相比对腹部手术的益处和危害。
我们检索了 Medline、Embase 和 CENTRAL 中的随机对照试验,以调查腹横肌前锯肌阻滞对接受任何腹部手术的成年患者术后疼痛管理的作用。两个主要结局是 24 小时累积阿片类药物消耗量和严重不良事件。我们进行了荟萃分析、试验序贯分析(TSA),评估了偏倚风险,并使用推荐评估、制定与评价(GRADE)方法呈现证据的确定性。
35 项随机分配 2418 名患者的试验被纳入荟萃分析。与安慰剂/无阻滞相比,腹横肌前锯肌阻滞可能减少 24 小时内静脉阿片类药物的累积消耗量(MD -10.42mg,96.7%CI -14.83 至 -6.01,TSA 调整的 CI -17.03 至 -3.82,p < 0.01)。有两项试验报告了严重不良事件。与安慰剂相比,腹横肌前锯肌阻滞对严重不良事件的数量可能没有影响(RR 1.49,96.7%CI 0.19 至 11.47,p = 0.68),但证据极不确定。所有试验结果均被评估为高偏倚风险。
腹横肌前锯肌阻滞可能减少 24 小时内阿片类药物的累积消耗量。报告的严重不良事件很少,腹横肌前锯肌阻滞对严重不良事件的数量可能没有影响,但证据极不确定。